Literature DB >> 3893512

Effect of oral N-acetylcysteine on mucus clearance.

A B Millar, D Pavia, J E Agnew, M T Lopez-Vidriero, D Lauque, S W Clarke.   

Abstract

Oral N-acetylcysteine has been advocated as a mucolytic agent for use in chronic bronchitis. We have investigated the effects of regular use of this drug at a dose of 200 mg thrice daily for 4 weeks in nine patients with chronic bronchitis on lung function, lung mucociliary clearance and sputum viscosity in a controlled, double-blind, crossover study. No significant differences were found in lung function, mucociliary clearance curves or sputum viscosity following treatment with N-acetylcysteine compared to control or placebo measurements.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893512

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  10 in total

Review 1.  [Good sense and nonsense of antitussive agents].

Authors:  A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal:  Internist (Berl)       Date:  2001-01       Impact factor: 0.743

Review 2.  Mucolytics: when dispensable, when necessary?

Authors:  P Dorow
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.

Authors:  B Olsson; M Johansson; J Gabrielsson; P Bolme
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy.

Authors:  A M Gallon
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

Review 5.  Chronic obstructive pulmonary disease and asthma. General and medical management with special attention to exacerbations.

Authors:  J P Kaajan
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

6.  Anti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease.

Authors:  U Rantzsch; G Vacca; R Dück; A Gillissen
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

Review 7.  Prodrug approach for increasing cellular glutathione levels.

Authors:  Ivana Cacciatore; Catia Cornacchia; Francesco Pinnen; Adriano Mollica; Antonio Di Stefano
Journal:  Molecules       Date:  2010-03-03       Impact factor: 4.411

Review 8.  Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature.

Authors:  Akaninyene Otu; Philip Langridge; David W Denning
Journal:  J Fungi (Basel)       Date:  2018-10-15

Review 9.  Scientific Papers and Patents on Substances with Unproven Effects. Part 2.

Authors:  Sergei V Jargin
Journal:  Recent Pat Drug Deliv Formul       Date:  2019

Review 10.  Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19.

Authors:  Asimina Dominari; Donald Hathaway Iii; Abdulhusein Kapasi; Trissa Paul; Sarabjot Singh Makkar; Valeria Castaneda; Sirisha Gara; Bishnu Mohan Singh; Kuchalambal Agadi; Maliha Butt; Varadha Retnakumar; Spandana Chittajallu; Rahima Taugir; Muhammad Khawar Sana; Manish Kc; Sarah Razzack; Niala Moallem; Alina Alvarez; Michael Talalaev
Journal:  World J Virol       Date:  2021-03-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.